Specialty Pharmaceutical Company dedicated to patients living with chronic conditions

« Back

Document Details

Filing Date
Jul 29, 2019
Document Date
Jul 29, 2019
Form Description
Post-effective amendment to an S-8 filing
Filing Group
Registration Statements
Company
BioDelivery Sciences International, Inc.
Issuer
BIODELIVERY SCIENCES INTERNATIONAL INC
BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic®
Thank you. We will get back to you soon